Pancreatic ductal adenocarcinoma and colon cancer patients with high levels of TP63 and Ago2 had a significantly lower overall survival time (Fig. 3E, F, Supplementary Fig. 3A–D). The gene discussed is AGO2; the disease is pancreatic ductal adenocarcinoma.